EDEN PRAIRIE, MINNESOTA — Starkey has announced that its Chief Technology Officer, Achin Bhowmik, Ph.D., has been appointed as an Industry Representative for the U.S. FDA Digital Health Advisory Committee.
The Digital Health Advisory Committee provides expert guidance to the FDA on matters related to the development and regulation of digital health technologies. Dr. Bhowmik’s selection reflects Starkey’s ongoing commitment to advancing innovation and enhancing patient care through cutting-edge technology.
“Achin’s appointment to serve the Digital Health Advisory Committee and represent the medical devices industry is a testament to his expertise and leadership in the field. At Starkey, we are dedicated to pushing the edge of innovation to build products that truly improve patients’ lives. Achin’s contributions will undoubtedly help shape the future of technology and ensure we continue to set the standard for excellence.”
“I am honored to support the FDA and contribute to the evolution of digital health,” said Bhowmik. “Starkey has always been at the forefront of integrating technology with compassionate care, and I look forward to bringing that perspective to the committee and collaborating to advance digital health solutions.”
Starkey’s commitment to innovation and caring for its patients is evident in its ongoing development of groundbreaking hearing solutions that combine advanced technology with a deep understanding of patient needs.
About Starkey
Starkey is a privately held, global hearing technology company headquartered in Eden Prairie, Minnesota. Founded by Bill Austin in 1967, Starkey is known for its innovative design, development and distribution of comprehensive digital hearing systems. Led today by President and CEO Brandon Sawalich, Starkey is the only American-owned provider of hearing technologies. The company has more than 5,000 employees, operates 29 facilities and does business in more than 100 markets worldwide. Learn more at starkey.com.
Source: Starkey
